A Caltech Library Service

Feasibility of Inpatient Continuous Glucose Monitoring During the COVID-19 Pandemic: Early Experience

Reutrakul, Sirimon and Genco, Matthew and Salinas, Harley and Sargis, Robert M. and Paul, Carlie and Eisenberg, Yuval and Fang, Jiali and Caskey, Rachel N. and Henkle, Sarah and Fatoorehchi, Sam and Osta, Amanda and Srivastava, Pavan and Johnson, Alexia and Messmer, Sarah E. and Barnes, Michelle and Pratuangtham, Sarida and Layden, Brian T. (2020) Feasibility of Inpatient Continuous Glucose Monitoring During the COVID-19 Pandemic: Early Experience. Diabetes Care, 43 (10). e137-e138. ISSN 0149-5992. doi:10.2337/dc20-1503.

Full text is not posted in this repository. Consult Related URLs below.

Use this Persistent URL to link to this item:


Continuous glucose monitoring (CGM) systems have been explored in a few studies for non–intensive care unit (ICU) patients (1–3). During the coronavirus disease 2019 (COVID-19) pandemic, shortage of personal protective equipment (PPE) became a concern. On 1 April 2020, the U.S. Food and Drug Administration announced it would not object to the use of CGM systems to assist with COVID-19 patient monitoring (4). This study was conducted to explore the feasibility of using CGM in noncritically ill patients hospitalized with COVID-19.

Item Type:Article
Related URLs:
URLURL TypeDescription
Reutrakul, Sirimon0000-0002-0686-1069
Sargis, Robert M.0000-0001-7061-2983
Layden, Brian T.0000-0003-2176-5654
Additional Information:© 2020 by the American Diabetes Association. Received 18 June 2020 and accepted 23 June 2020. This article is part of a special article collection available at The authors thank the nursing staff of 7East, University of Illinois Hospital & Health Sciences System, and the endocrinology fellows for their assistance in the study and their dedicated care for the COVID-19–positive patients. They acknowledge Rebecca S. Monson and Kirstie K. Danielson (University of Illinois at Chicago) for their assistance in the study. This study was supported by the Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago. Dexcom provided equipment support. Dexcom had no role in the study design, data collection, or analysis. No potential conflicts of interest relevant to this article were reported. Author Contributions: S.R. designed the study, researched and analyzed the data, and wrote and edited the manuscript. M.G., H.S., C.P., J.F., R.N.C., S.H., S.F., A.O., P.S., A.J., S.E.M., and M.B. researched data and reviewed and edited the manuscript. S.P. analyzed the data and contributed to the discussion. R.M.S., Y.E., and B.T.L. designed the study, contributed to the discussion, and reviewed and edited the manuscript. S.R. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Funding AgencyGrant Number
University of Illinois, ChicagoUNSPECIFIED
Issue or Number:10
Record Number:CaltechAUTHORS:20200818-151255840
Persistent URL:
Official Citation:Feasibility of Inpatient Continuous Glucose Monitoring During the COVID-19 Pandemic: Early Experience. Sirimon Reutrakul, Matthew Genco, Harley Salinas, Robert M. Sargis, Carlie Paul, Yuval Eisenberg, Jiali Fang, Rachel N. Caskey, Sarah Henkle, Sam Fatoorehchi, Amanda Osta, Pavan Srivastava, Alexia Johnson, Sarah E. Messmer, Michelle Barnes, Sarida Pratuangtham, Brian T. Layden. Diabetes Care Oct 2020, 43 (10) e137-e138; DOI: 10.2337/dc20-1503
Usage Policy:No commercial reproduction, distribution, display or performance rights in this work are provided.
ID Code:105013
Deposited By: George Porter
Deposited On:19 Aug 2020 19:50
Last Modified:16 Nov 2021 18:38

Repository Staff Only: item control page